Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases

Free Radical Research

Volumn 33, Issue SUPPL., 2000, Pages

  Aviram, M ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

carotene; Antioxidants; Atherosclerosis; Cardiovascular diseases; Flavonoids; HDL; LDL; Lipid peroxidation; Lipoproteins; Lycopene; Paraoxonase; Polyphenols; Vitamin C; Vitamin E

Indexed keywords

ALDEHYDE; ALPHA CAROTENE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CAROTENOID; CHOLESTEROL; CRYPTOXANTHIN; DOCOSAHEXAENOIC ACID; FLAVONOID; HYDROXY FATTY ACID; ICOSAPENTAENOIC ACID; ISOPROSTANE; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; LYCOPENE; MARKER; OXYSTEROL; SELENIUM; XANTHOPHYLL; ZEAXANTHIN;

ARTERY WALL; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL ADHESION; CLINICAL TRIAL; CONFERENCE PAPER; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; HEART PROTECTION; HUMAN; LIPID OXIDATION; LIPID PEROXIDATION; OXIDATIVE STRESS;

ANTIOXIDANTS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DNA DAMAGE; HUMANS; LIPOPROTEINS, LDL; OXIDATIVE STRESS;

EID: 0034525341     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (88)

1. Antioxidants in human health and disease
2. LDL oxidation and its pathological significance
3. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity
4. The oxidation hypothesis of atherosclerosis
5. Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis
6. LDL-platelet interaction under oxidative stress induces macrophage foam cell formation
7. Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans
8. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins
9. Antioxidants in restenosis and atherosclerosis
10. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and antioxidants in arterial cells and in blood lipoproteins: A need for a dual approach
11. Oxidized low density lipoprotein: Atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase
12. Plasma LDL oxidation leads to its aggregation in the atherosclerotic apolipoprotein E-deficient mice
13. Lesion low density lipoprotein in atherosclerotic apolipoprotein E-deficient transgenic mice and in humans is oxidized and aggregated
14. Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants
15. Oxidation of low-density lipoproteins: Questions of initiation, propagation, and the effect of antioxidants
16. Oxidative modification of low density lipoprotein and its relation to atherosclerosis
17. Effect of lipoproteins and platelets on macrophage cholesterol metabolism
18. Mechanisms of oxidation, antioxidants, and atherosclerosis
19. Lipoprotein oxidation: Mechanistic aspects, methodological approaches and clinical relevance
20. Activation of NADPH oxidase is required for macrophage-mediated oxidation of low-density lipoprotein
21. Localization of a consecutively active, phagocyte-like NADPH oxidase in rabbit aortic adventition: Enhancement by angiotensin II
22. Basic mechanisms oxidation, inflammation, and genetics
23. Atherosclerosis - An inflammatory disease
24. Oxysterols and atherosclerosis
25. The role of oxidized lipoprotein in atherogenesis
26. Lipoprotein receptor interactions are not required for monocyte oxidation of LDL
27. The other side of scavenger receptors: Pattern recognition for host defense
28. Paraoxonase and coronary heart disease
29. Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: A possible role for angiotensin II
30. Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients
31. Increased plasma lipoprotein lipid peroxidation in apo E-deficient mice
32. Antioxidant consumption and risk of coronary heart disease: Emphasis on vitamin C, vitamin E, and β-carotene a statement for healthcare professionals from the American Heart Association
33. Antioxidant vitamins and prevention of cardiovascular disease: Laboratory, epidemiological and clinical trial data
34. Antioxidants are useful in preventrug cardiovascular disease: A debate. Con antioxidants
35. Vitamin C intake and mortality among a sample of the United States population
36. Vitamin E and vitamin C supplement use and risk of all cause and coronary heart disease mortality in older persons: The established populations for epidemiologic studies of the elderly
37. Antioxidants and atherosclerotic heart disease
38. The yin and yang of oxidation in the development of the fatty streak: A review based on the 1994 George Lyman Duff Memorial Lecture
39. LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: Role of prooxidants vs. antioxidants
40. Low plasma vitamins E and C: Increased risk of angina in Scottishmen
41. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
42. Vitamin E consumption and the risk of coronary disease in women
43. Vitamin E consumption and the risk of coronary heart disease in men
44. Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology
45. Antioxidant defense: Vitamins E and C and carotenoids
46. Antioxidant vitamin-cardiovascular disease hypothesis is still promising, but still unproven: The need for randomized trials
47. The antioxidant vitamins and cardiovascular disease: A critical review of epidemiologic and clinical trial data
48. Effect of vitamin E and probucol on dietary cholesterol-induced atherosclerosis in rabbits
49. Dietary cholesterol induced changes of protein kinase C and the effect of vitamin E in rabbit aorta smooth muscle cells
50. Both intracellular and extracellular vitamin C inhibit atherogenic modification of LDL by human vascular endothelial cells
51. Serum ascorbic acid and cardiovascular disease prevalence in U.S. adults
52. Combination of vitamin C and E alters the response to coronary balloon injury in the pig
53. Ascorbate and urate are the strongest determinants of plasma antioxidative capacity and serum lipid resistance to oxidation in Finnish men
54. Preferential inhibition of LDL oxidation by the all-trans isomer of carotene in comparison to the 9-cis-carotene
55. Supplementation with beta-carotene in vivo and in vitro does not inhibit low density lipoprotein oxidation
56. Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits
57. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease
58. Epidemiological evidence for betacarotene in prevention of cancer and cardiovascular disease
59. β-Carotene affects antioxidant status in non-insulin-dependent diabetes mellitus
60. Tomato lycopene and β-carotene inhibit low density lipoprotein oxidation and this effect depends on the lipoprotein vitamin E content
61. β-carotene and α-tocopherol are synergistic antioxidants
62. Carotenoids enhance vitamin E antioxidant efficiency
63. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers
64. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
65. Beta-carotene intake and risk of nonfatal acute myocardial infarction in women
66. Serum antioxidants and myocardial infarction: Are low levels of carotenoids and α-tocopherol risk factors for myocardial infarction?
67. Nutrition intervention trials in Linxian, Chaina: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population
68. Randomized trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in mean with previous myocardial infarction
69. Serial coronary angiographic evidence that anti-oxidant vitamin intake reduces progression of coronary artery atherosclerosis
70. Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering
71. Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival)
72. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty: Multivitamins and probucol study group
73. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: The probucol angioplasty restenosis trial
74. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study
75. Polyphenolic flavonoids inhibit macrophage-mediated oxidation of LDL and attenuate atherogenesis
76. Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation
77. Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification
78. Licorice extract and its major polyphenol glabridin protect low density lipoprotein against lipid peroxidation: In vitro and ex-vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice
79. Macrophage enrichment with the isoflavan glabridin inhibits superoxide-induced cell-mediated oxidation of low density lipoprotein (LDL): A possible role for protein kinase C
80. Dietary consumption of ginger extract attenuates development of atherosclerosis in the atheroscletrotic apolipoprotein E deficient mice: Hypocholesterolemic and antioxidative effects
81. Pomegranate juice consumption reduces oxidative stress, low density lipoprotein modifications and platelet aggregation: Studies in the atherosclerotic apolipoprotein E deficient mice and in human
82. Recent trends in glutathione biochemistry, glutathione-protein interactions: A molecular link between oxidative stress and cell proliferation?
83. Dietary selenium increases cellular glutathione peroxidase activity and reduces the enhanced susceptibility to lipid peroxidation of plasma and low density lipoprotein in kidney transplant recipients
84. Does paroaoxonase play a role in susceptibility to cardiovascular disease?
85. Paraoxonase inhibits high density lipoprotein (HDL) oxidation and preserves its functions: A possible peroxidative role for paraoxonase
86. Human serum paroaoxnases (PON 1), Q and R selectively decrease lipid peroxides in coronary and carotid atherosclerotic lesions: PON 1 esterase and peroxidase-like activities
87. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants
88. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation